OPCH · Option Care Health, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.35B | - | $1.44B | $1.42B | $1.15B | - | $1.28B | $1.23B | $1.15B | - |
| Cost of Revenue | $1.09B | - | $1.16B | $1.15B | $1.07B | - | $1.02B | $977.82M | $907.55M | - |
| Gross Profit | $262.01M | - | $272.90M | $269.04M | $263.05M | - | $256.75M | $249.37M | $238.50M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $174.56M | - | $172.10M | $170.09M | $168.12M | - | $157.00M | $153.78M | $154.74M | - |
| Total Operating Expenses | $189.47M | - | $188.40M | $186.33M | $183.86M | - | $171.66M | $168.69M | $169.47M | - |
| D&A | $14.91M | - | $16.29M | $16.24M | $15.75M | - | $14.66M | $14.91M | $14.73M | - |
| Operating Income | $72.55M | - | $84.51M | $82.71M | $79.19M | - | $85.09M | $80.67M | $69.03M | - |
| Interest Expense | $13.30M | - | $14.15M | $14.45M | $13.20M | - | $12.35M | $12.60M | $13.20M | - |
| Income Tax | $15.66M | - | $17.15M | $18.34M | $16.81M | - | $19.70M | $19.00M | $12.16M | - |
| Net Income | $45.34M | - | $51.82M | $50.52M | $46.74M | - | $53.86M | $53.04M | $44.79M | - |
| EPS - Basic | $0.29 | - | $0.32 | $0.31 | $0.28 | - | $0.32 | $0.31 | $0.26 | - |
| EPS - Diluted | $0.29 | - | $0.32 | $0.31 | $0.28 | - | $0.31 | $0.30 | $0.26 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $177.32M | $232.62M | $309.82M | $198.82M | $171.37M | $412.56M | $483.03M | $376.87M | $219.51M | $343.85M |
| Accounts Receivable | $516.44M | $473.57M | $474.50M | $481.25M | $476.65M | $409.73M | $428.95M | $468.30M | $573.65M | $377.66M |
| Inventory | $415.69M | $471.15M | $415.72M | $403.54M | $369.03M | $388.13M | $310.60M | $281.42M | $241.95M | $274.00M |
| Accounts Payable | $545.02M | $639.83M | $627.87M | $590.22M | $528.85M | $610.78M | $591.97M | $535.69M | $485.74M | $426.51M |
| Current Assets | $1.20B | $1.26B | $1.28B | $1.18B | $1.10B | $1.32B | $1.32B | $1.23B | $1.13B | $1.09B |
| Total Assets | $3.38B | $3.46B | $3.48B | $3.38B | $3.31B | $3.42B | $3.43B | $3.35B | $3.25B | $3.22B |
| Current Liabilities | $729.75M | $829.35M | $823.91M | $773.62M | $713.66M | $780.15M | $763.22M | $695.41M | $636.95M | $618.31M |
| Long-term Debt | $1.15B | $1.15B | $1.16B | $1.10B | $1.10B | $1.10B | $1.11B | $1.11B | $1.06B | $1.06B |
| Total Liabilities | $2.03B | $2.13B | $2.12B | $2.02B | $1.96B | $2.02B | $2.00B | $1.94B | $1.82B | $1.80B |
| Stockholders' Equity | $1.35B | $1.33B | $1.36B | $1.36B | $1.35B | $1.40B | $1.43B | $1.41B | $1.43B | $1.42B |
| Retained Earnings | $922.26M | $876.92M | $818.42M | $766.60M | $716.08M | $669.34M | $609.20M | $555.35M | $502.30M | $457.51M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($12.11M) | - | - | - | ($7.21M) | - | - | - | ($68.78M) | - |
| Investing Cash Flow | ($9.32M) | - | - | - | ($126.69M) | - | - | - | ($5.82M) | - |
| Financing Cash Flow | ($33.87M) | - | - | - | ($107.29M) | - | - | - | ($49.73M) | - |
| CapEx | $9.05M | - | - | - | $9.37M | - | - | - | $5.82M | - |
| Free Cash Flow | ($21.16M) | - | - | - | ($16.59M) | - | - | - | ($74.60M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 19.4% | - | 19.0% | 19.0% | 23.0% | - | 20.1% | 20.3% | 20.8% | - |
| Operating margin | 5.4% | - | 5.9% | 5.8% | 6.9% | - | 6.7% | 6.6% | 6.0% | - |
| EBITDA margin | 6.5% | - | 7.0% | 7.0% | 8.3% | - | 7.8% | 7.8% | 7.3% | - |
| Net margin | 3.4% | - | 3.6% | 3.6% | 4.1% | - | 4.2% | 4.3% | 3.9% | - |
| Free cash flow margin | -1.6% | - | - | - | -1.4% | - | - | - | -6.5% | - |
| FCF / Net income | -0.47 | - | - | - | -0.35 | - | - | - | -1.67 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 12.9% | - | 12.0% | 12.0% | 14.7% | - | 12.3% | 12.5% | 13.5% | - |
| Effective tax rate | 25.7% | - | 24.9% | 26.6% | 26.5% | - | 26.8% | 26.4% | 21.4% | - |
| Return on assets | 1.3% | - | 1.5% | 1.5% | 1.4% | - | 1.6% | 1.6% | 1.4% | - |
| Return on equity | 3.4% | - | 3.8% | 3.7% | 3.5% | - | 3.8% | 3.8% | 3.1% | - |
| Return on invested capital | 2.2% | - | 2.5% | 2.5% | 2.4% | - | 2.5% | 2.4% | 2.2% | - |
| Liquidity | ||||||||||
| Current ratio | 1.64 | 1.53 | 1.56 | 1.52 | 1.54 | 1.70 | 1.73 | 1.77 | 1.77 | 1.77 |
| Quick ratio | 1.07 | 0.96 | 1.05 | 1.00 | 1.02 | 1.20 | 1.32 | 1.36 | 1.39 | 1.33 |
| Cash ratio | 0.24 | 0.28 | 0.38 | 0.26 | 0.24 | 0.53 | 0.63 | 0.54 | 0.34 | 0.56 |
| Leverage | ||||||||||
| Debt / Equity | 0.85 | 0.87 | 0.85 | 0.81 | 0.82 | 0.79 | 0.77 | 0.78 | 0.74 | 0.74 |
| Debt / Assets | 0.34 | 0.33 | 0.33 | 0.33 | 0.33 | 0.32 | 0.32 | 0.33 | 0.33 | 0.33 |
| Debt / EBITDA | 13.18 | - | 11.46 | 11.15 | 11.63 | - | 11.08 | 11.57 | 12.61 | - |
| Interest coverage | 5.5x | - | 6.0x | 5.7x | 6.0x | - | 6.9x | 6.4x | 5.2x | - |
| Equity multiplier | 2.50 | 2.61 | 2.56 | 2.49 | 2.45 | 2.44 | 2.40 | 2.37 | 2.27 | 2.26 |
| Liabilities / Assets | 0.60 | 0.62 | 0.61 | 0.60 | 0.59 | 0.59 | 0.58 | 0.58 | 0.56 | 0.56 |
| Efficiency | ||||||||||
| Asset turnover | 0.40 | - | 0.41 | 0.42 | 0.35 | - | 0.37 | 0.37 | 0.35 | - |
| Inventory turnover | 2.62 | - | 2.80 | 2.84 | 2.90 | - | 3.29 | 3.47 | 3.75 | - |
| Days sales outstanding | 140d | - | 121d | 124d | 152d | - | 122d | 139d | 183d | - |
| Days inventory outstanding | 139d | - | 131d | 128d | 126d | - | 111d | 105d | 97d | - |
| Days payable outstanding | 183d | - | 197d | 188d | 180d | - | 211d | 200d | 195d | - |
| Cash conversion cycle | 96d | - | 54d | 65d | 97d | - | 22d | 44d | 85d | - |
| Valuation | ||||||||||
| P / E | 92.8x | - | 86.8x | 104.8x | 124.8x | - | 101.0x | 92.3x | 129.0x | - |
| P / B | 3.2x | - | 3.3x | 3.9x | 4.3x | - | 3.8x | 3.4x | 4.1x | - |
| P / S | 3.2x | - | 3.2x | 3.8x | 5.1x | - | 4.2x | 3.9x | 5.1x | - |
| EV / EBITDA | 59.9x | - | 53.3x | 63.0x | 71.2x | - | 60.2x | 58.1x | 80.3x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 17.9% | - | 12.2% | 15.4% | 0.0% | - | 17.0% | 14.8% | 12.8% | - |
| Revenue CAGR (3y) | 10.0% | - | 12.0% | 13.0% | 7.8% | - | 12.8% | 12.6% | 14.7% | - |
| Revenue CAGR (5y) | 12.2% | - | 12.9% | 13.8% | 10.2% | - | 15.7% | 45.0% | 45.0% | - |
| Gross profit growth (YoY) | -0.4% | - | 6.3% | 7.9% | 10.3% | - | 1.0% | -0.6% | 4.1% | - |
| Operating income growth (YoY) | -8.4% | - | -0.7% | 2.5% | 14.7% | - | 5.0% | -2.1% | 3.6% | - |
| Net income growth (YoY) | -3.0% | - | -3.8% | -4.8% | 4.4% | - | -4.3% | -53.6% | 14.2% | - |
| EPS growth (YoY) | 3.6% | - | 3.2% | 3.3% | 7.7% | - | 0.0% | -52.4% | 23.8% | - |
| EPS CAGR (3y) | 11.4% | - | 15.1% | 17.7% | 18.1% | - | 15.7% | 18.6% | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -27.6% | - | - | - | 77.8% | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 0.0% | -5.5% | -4.7% | -3.6% | -5.5% | -1.2% | -1.0% | -4.3% | 5.8% | 2.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$5.56B totalReportable Segment$5.56B · 100.0%
Peer comparison
Same SIC group: Services-Home Health Care Services
Comparing Option Care Health against the 5 most active filers in the same SIC group.